Act1 (NT) Blocking Peptide

Act1 (NT) Blocking Peptide

Product No.: A188

[product_table name="All Top" skus="A188"]

- -
- -
Product Type
Blocking Peptide
Alternate Names
CIKS, C6orf2,C6orf4, ,6orf5, C6orf6, MGC3581, DKFZp586G0522, TRAF3IP2

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Product Concentration
0.2 mg/ml
Amino Acid Location
This peptide sequence is located at amino acids 2 to 15 of Human Act1 protein.
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
Next Day Ambient
Amino Acid Sequence
14 amino amino terminus of human CIKS.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Act1 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Antigen Details

References & Citations

1. Leonardi A, Chariot A, Claudio E, Cunningham K, Siebenlist U. CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc Natl Acad Sci USA. 2000;97(19):10494-9. 2. Li X, Commane M, Nie H, Hua X, Chatterjee-Kishore M, Wald D, Haag M, Stark GR. Act1, an NF-kappa B activating protein. Proc Natl Acad Sci USA. 2000;97(19):10489-93.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.